REFERENCES
- Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005; 4 (5): 281–288
- Goodin DS, Frohman EM, Garmany GP, Jr, et al. Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002; 58 (2): 169–178
- Wingerchuk DM. Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep 2003; 3 (3): 256–264
- Prineas JW, McDonald WI, Franklin RJM. Demyelinating diseases. In: Graham DI, Lantos PL, eds. Green field's neuropathology, Vol. 2, 7th edn, London: Arnold, 2002: pp. 471-550
- Cohen O, Steiner-Birmanns B, Biran I, et al. Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol 2001; 58 (5): 797–801
- Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelina-tion. Ann Neurol 2000; 47 (6): 707–717
- Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin 2005; 23 (1): 77–105
- Dale RC, Church AJ, Cardoso F, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001; 50 (5): 588–595
- Pohl D, Rostasy K, Reiber H, et al. CSF characteristics in early-onset multiple sclerosis. Neurology 2004; 63 (10): 1966–1967
- Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004; 127 (Pt 9): 1942–1947
- Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120 (Pt 11): 2059–2069
- Hahn CD, Shroff MM, Blaser SI, et al. MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology 2004; 62 (5): 806-808
- Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000; 123 (Pt 12): 2407–2422
- Hynson JL, Kornberg AL Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001; 56 (10): 1308–1312
- Hung KL, Liao HT, Tsai ML. The spectrum of postinfectious encephalomyelitis. Brain Dey 2001; 23 (1): 42–45
- Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology 2002; 59 (8): 1224–1231
- Murthy SN, Faden HS, Cohen ME, et al. Acute disseminated encephalomyelitis in children. Pediatrics 2002; 110(2 Pt 1): e21
- Anlar B, Basaran C, Kose G, et al. Acute disseminated encepha-lomyelitis in children: Outcome and prognosis. Neuropediatrics 2003; 34 (4): 194–199
- Gupte G, Stonehouse M, Wassmer E, et al. Acute disseminated encephalomyelitis: A review of 18 cases in childhood. J Paediatr Child Health 2003; 39 (5): 336–342
- Idrissova ZhR, Boldyreva MN, Dekonenko EP, et al. Acute disseminated encephalomyelitis in children: Clinical features and HLA-DR linkage. Eur J Neurol 2003; 10 (5): 537–546
- Mikaeloff Y, Suissa S, Vallee L, et al. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. J Pediatr 2004; 144 (2): 246–252
- Leake JA, Albani S, Kao AS, et al. Acute disseminated encepha-lomyelitis in childhood: Epidemiologic, clinical and laboratory features. Pediatr Infect Dis J2004; 23 (8): 756-764
- Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients. Neurology 2001; 56 (10): 1313–1318
- Hahn CD, Miles BS, MacGregor DL, et al. Neurocognitive outcome after acute disseminated encephalomyelitis. Pediatr Neurol 2003; 29 (2): 117–123
- Pohl D, Rostasy K, Gartner J, et al. Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 2005; 64 (5): 888–890